RxDoctor Payments Data

Amanda Kierbs, NP

Adult Health · Urbana, ILNPI 1407397284

Payments from drug & device makers

$1,196in general payments, 2019–2025

Across 50 payments — averaging $23.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$174
  • EMD Serono, Inc.$165
  • Lundbeck LLC$150
  • Abbott$139
  • Amgen$137
  • Biohaven Pharmaceuticals, Inc.$70
  • plus $362 from 13 others

What the payments were for

  • Food & beverage$1,07790%
  • Education$11910%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,196 in reported general payments places this provider in the 75th percentile of 553 adult health providers in Illinois.

See all adult health providers in Illinois

Medicare billing

Part B allowed, 2024
$15,061
Medicare patients
119
Services billed
168

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XcopriCenobamate46$63,245
FycompaPerampanel22$46,362
BriviactBrivaracetam16$22,411
EpidiolexCannabidiol (Cbd)12$20,763
Nurtec OdtRimegepant Sulfate13$18,847
Levetiracetam316$16,902
Clobazam96$13,311
Lacosamide85$13,155
Aimovig AutoinjectorErenumab-Aooe13$9,397
Carbamazepine27$2,325
Divalproex Sodium ErDivalproex Sodium28$2,129
Levetiracetam ErLevetiracetam16$1,977
Divalproex Sodium46$1,586
Lamotrigine103$1,342
Topiramate45$969

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
SK Life Science, Inc.Xcopri$14$63,24546 claims
UCB, Inc.Briviact$61$22,41116 claims
Upsher-smith Laboratories LLCTopiramate$34$96945 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 553 adult health providers in Illinois.

Other adult health in Urbana

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →